Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Complement Membrane Attack Complex | 19 | 2016 | 112 | 2.040 |
Why?
|
Diabetes, Gestational | 7 | 2023 | 1184 | 1.880 |
Why?
|
Glucose Intolerance | 4 | 2023 | 577 | 1.810 |
Why?
|
Eukaryotic Initiation Factor-2 | 11 | 2019 | 190 | 1.650 |
Why?
|
Complement System Proteins | 14 | 2015 | 795 | 1.320 |
Why?
|
Diabetic Angiopathies | 4 | 2016 | 818 | 1.030 |
Why?
|
Peptide Chain Initiation, Translational | 3 | 2013 | 103 | 0.950 |
Why?
|
Thiazoles | 8 | 2014 | 1483 | 0.850 |
Why?
|
Eicosapentaenoic Acid | 3 | 2015 | 582 | 0.850 |
Why?
|
Complement Activation | 11 | 2016 | 453 | 0.770 |
Why?
|
Thiazolidinediones | 4 | 2013 | 476 | 0.760 |
Why?
|
Clotrimazole | 3 | 2013 | 77 | 0.760 |
Why?
|
Protein Biosynthesis | 11 | 2013 | 2126 | 0.750 |
Why?
|
Erythrocytes | 11 | 2017 | 2455 | 0.720 |
Why?
|
Infant, Newborn, Diseases | 2 | 2022 | 582 | 0.710 |
Why?
|
Chromans | 2 | 2013 | 122 | 0.700 |
Why?
|
Blood Glucose | 11 | 2023 | 6254 | 0.630 |
Why?
|
Erythrocyte Membrane | 10 | 2017 | 442 | 0.630 |
Why?
|
Antineoplastic Agents | 16 | 2019 | 13693 | 0.610 |
Why?
|
Fetal Diseases | 1 | 2022 | 903 | 0.590 |
Why?
|
Hydrazones | 6 | 2014 | 102 | 0.590 |
Why?
|
Histidine | 1 | 2017 | 313 | 0.570 |
Why?
|
Platelet Activation | 4 | 2010 | 674 | 0.560 |
Why?
|
Postpartum Period | 2 | 2023 | 1086 | 0.540 |
Why?
|
Eukaryotic Initiation Factor-4G | 5 | 2014 | 68 | 0.540 |
Why?
|
RNA, Transfer, Met | 1 | 2015 | 14 | 0.530 |
Why?
|
Hypoglycemia | 1 | 2022 | 861 | 0.520 |
Why?
|
Urea | 5 | 2019 | 450 | 0.520 |
Why?
|
Nitro Compounds | 2 | 2012 | 74 | 0.500 |
Why?
|
Indoles | 3 | 2012 | 1839 | 0.500 |
Why?
|
Guanosine Triphosphate | 1 | 2015 | 321 | 0.480 |
Why?
|
Eukaryotic Initiation Factor-4E | 5 | 2014 | 107 | 0.470 |
Why?
|
Glucose Tolerance Test | 4 | 2023 | 1151 | 0.430 |
Why?
|
Hemolysis | 6 | 2017 | 420 | 0.430 |
Why?
|
Phosphorylation | 13 | 2019 | 8436 | 0.430 |
Why?
|
Glycosylation | 6 | 2020 | 1128 | 0.430 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2012 | 41 | 0.420 |
Why?
|
Complement C3 | 3 | 2009 | 461 | 0.420 |
Why?
|
Endothelium, Vascular | 7 | 2016 | 4459 | 0.420 |
Why?
|
Apolipoproteins E | 3 | 2016 | 1438 | 0.400 |
Why?
|
Hemoglobinuria, Paroxysmal | 2 | 2009 | 102 | 0.400 |
Why?
|
Fish Oils | 1 | 2015 | 470 | 0.390 |
Why?
|
Calcium | 15 | 2004 | 5755 | 0.370 |
Why?
|
5' Untranslated Regions | 2 | 2015 | 249 | 0.370 |
Why?
|
Oligospermia | 1 | 2009 | 59 | 0.330 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2009 | 69 | 0.330 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 7 | 1991 | 494 | 0.330 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1149 | 0.320 |
Why?
|
Structure-Activity Relationship | 11 | 2019 | 3130 | 0.300 |
Why?
|
Bacteriocins | 4 | 2011 | 90 | 0.280 |
Why?
|
Thrombophilia | 1 | 2009 | 305 | 0.280 |
Why?
|
eIF-2 Kinase | 3 | 2013 | 150 | 0.270 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2021 | 3338 | 0.270 |
Why?
|
Mice, Knockout | 9 | 2016 | 14561 | 0.270 |
Why?
|
Gene Knockout Techniques | 1 | 2009 | 808 | 0.270 |
Why?
|
Anemia, Hemolytic | 2 | 2005 | 168 | 0.270 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 12073 | 0.250 |
Why?
|
Thiones | 1 | 2004 | 46 | 0.250 |
Why?
|
Potassium | 10 | 1993 | 1336 | 0.250 |
Why?
|
RNA Cap Analogs | 1 | 2004 | 13 | 0.250 |
Why?
|
Mice | 31 | 2017 | 81201 | 0.240 |
Why?
|
Animals | 48 | 2017 | 168768 | 0.240 |
Why?
|
Nitric Oxide | 3 | 2010 | 2132 | 0.240 |
Why?
|
Fluorescein | 1 | 2004 | 171 | 0.230 |
Why?
|
Sodium | 10 | 1993 | 1622 | 0.230 |
Why?
|
Cell Line, Tumor | 14 | 2019 | 16690 | 0.230 |
Why?
|
Infertility, Male | 2 | 2005 | 409 | 0.230 |
Why?
|
Receptors, Complement | 1 | 2004 | 264 | 0.220 |
Why?
|
Myasthenia Gravis, Autoimmune, Experimental | 2 | 2012 | 6 | 0.220 |
Why?
|
Pregnancy | 8 | 2023 | 29144 | 0.210 |
Why?
|
Cell Division | 5 | 2001 | 4569 | 0.210 |
Why?
|
Atherosclerosis | 2 | 2016 | 3444 | 0.210 |
Why?
|
Crosses, Genetic | 2 | 2016 | 791 | 0.200 |
Why?
|
Cell Membrane Permeability | 4 | 1993 | 590 | 0.200 |
Why?
|
Mice, Inbred DBA | 3 | 2013 | 642 | 0.200 |
Why?
|
Reproduction | 1 | 2005 | 668 | 0.190 |
Why?
|
Cell Proliferation | 10 | 2019 | 10483 | 0.180 |
Why?
|
Mice, Nude | 4 | 2015 | 3689 | 0.180 |
Why?
|
Aniline Compounds | 1 | 2004 | 986 | 0.180 |
Why?
|
3T3 Cells | 5 | 2001 | 1101 | 0.170 |
Why?
|
Fetal Macrosomia | 1 | 2020 | 124 | 0.170 |
Why?
|
Ion Channels | 3 | 1990 | 1056 | 0.170 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 693 | 0.170 |
Why?
|
Glucose | 5 | 2022 | 4398 | 0.160 |
Why?
|
Parity | 1 | 2021 | 929 | 0.160 |
Why?
|
Blood Platelets | 1 | 2009 | 2509 | 0.160 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14723 | 0.160 |
Why?
|
Digitalis | 2 | 1989 | 14 | 0.160 |
Why?
|
Heme | 1 | 2019 | 307 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2013 | 3554 | 0.150 |
Why?
|
Plants, Toxic | 2 | 1989 | 76 | 0.150 |
Why?
|
Humans | 61 | 2023 | 744366 | 0.150 |
Why?
|
Area Under Curve | 1 | 2021 | 1655 | 0.150 |
Why?
|
Plants, Medicinal | 2 | 1989 | 167 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 4 | 2019 | 730 | 0.140 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 871 | 0.140 |
Why?
|
Cyclin D1 | 2 | 2013 | 463 | 0.140 |
Why?
|
Streptozocin | 1 | 2016 | 196 | 0.140 |
Why?
|
Breast Neoplasms | 2 | 2015 | 20824 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 1996 | 599 | 0.130 |
Why?
|
Complement C5 | 2 | 2009 | 112 | 0.130 |
Why?
|
Female | 21 | 2023 | 380193 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2004 | 1161 | 0.130 |
Why?
|
Infant, Newborn | 4 | 2022 | 25628 | 0.130 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2004 | 1344 | 0.130 |
Why?
|
Sulfonamides | 1 | 2004 | 1940 | 0.130 |
Why?
|
Melanoma | 2 | 2012 | 5511 | 0.130 |
Why?
|
Cerebrospinal Fluid | 2 | 1989 | 535 | 0.120 |
Why?
|
Rats | 12 | 2013 | 24252 | 0.120 |
Why?
|
Platelet-Derived Growth Factor | 2 | 1994 | 625 | 0.120 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5867 | 0.120 |
Why?
|
Neoplasm Transplantation | 2 | 2015 | 2086 | 0.120 |
Why?
|
Complement C9 | 3 | 2009 | 16 | 0.120 |
Why?
|
Growth Inhibitors | 1 | 1995 | 385 | 0.120 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2014 | 76 | 0.120 |
Why?
|
Enzyme Activators | 1 | 2013 | 57 | 0.120 |
Why?
|
Macrophage Activation | 1 | 2016 | 560 | 0.110 |
Why?
|
Neuromuscular Junction | 2 | 2012 | 397 | 0.110 |
Why?
|
Models, Molecular | 7 | 2019 | 5451 | 0.110 |
Why?
|
Mice, Inbred Strains | 2 | 2009 | 1828 | 0.110 |
Why?
|
Lysine | 1 | 2017 | 1007 | 0.110 |
Why?
|
Molecular Structure | 5 | 2019 | 1899 | 0.110 |
Why?
|
Papillary Muscles | 1 | 1993 | 203 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2014 | 11726 | 0.110 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 215 | 0.110 |
Why?
|
Tumor Cells, Cultured | 6 | 2011 | 6313 | 0.110 |
Why?
|
Testis | 2 | 2006 | 804 | 0.100 |
Why?
|
Gestational Age | 2 | 2020 | 3493 | 0.100 |
Why?
|
Indazoles | 1 | 2014 | 290 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2015 | 13035 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 1995 | 692 | 0.100 |
Why?
|
Mice, Transgenic | 5 | 2017 | 9735 | 0.100 |
Why?
|
Open Reading Frames | 1 | 2015 | 811 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2021 | 21748 | 0.100 |
Why?
|
Peptides | 4 | 2014 | 4410 | 0.100 |
Why?
|
Ouabain | 5 | 1989 | 264 | 0.100 |
Why?
|
Aorta | 2 | 2016 | 2062 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2017 | 1115 | 0.100 |
Why?
|
Biological Transport | 6 | 1996 | 2120 | 0.100 |
Why?
|
Potassium Channels | 3 | 1993 | 563 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2019 | 10943 | 0.100 |
Why?
|
Prospective Studies | 4 | 2023 | 53290 | 0.090 |
Why?
|
Mice, Inbred C57BL | 5 | 2016 | 21833 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2017 | 1359 | 0.090 |
Why?
|
Spermatozoa | 2 | 2005 | 625 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2013 | 18034 | 0.090 |
Why?
|
Molecular Mimicry | 2 | 2014 | 201 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2943 | 0.090 |
Why?
|
Prenatal Care | 1 | 2017 | 1092 | 0.090 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 2009 | 23 | 0.090 |
Why?
|
Exons | 2 | 2009 | 2439 | 0.090 |
Why?
|
Nitroso Compounds | 1 | 2009 | 72 | 0.080 |
Why?
|
Complement Pathway, Classical | 1 | 2009 | 97 | 0.080 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2009 | 126 | 0.080 |
Why?
|
Nitric Oxide Donors | 1 | 2009 | 121 | 0.080 |
Why?
|
Infant | 3 | 2022 | 35134 | 0.080 |
Why?
|
Guinea Pigs | 3 | 2000 | 1386 | 0.080 |
Why?
|
Random Allocation | 1 | 2013 | 2428 | 0.080 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2009 | 254 | 0.080 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2009 | 429 | 0.080 |
Why?
|
Azides | 1 | 2008 | 116 | 0.080 |
Why?
|
Kinetics | 6 | 1994 | 6476 | 0.080 |
Why?
|
CHO Cells | 2 | 2001 | 1409 | 0.080 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 1988 | 69 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1889 | 0.080 |
Why?
|
Complement Inactivator Proteins | 3 | 2000 | 79 | 0.080 |
Why?
|
Alkynes | 1 | 2008 | 306 | 0.070 |
Why?
|
Intracranial Pressure | 1 | 1989 | 326 | 0.070 |
Why?
|
Transfection | 3 | 2000 | 5895 | 0.070 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2011 | 1369 | 0.070 |
Why?
|
Cricetinae | 2 | 2001 | 2475 | 0.070 |
Why?
|
Umbilical Veins | 2 | 2000 | 433 | 0.070 |
Why?
|
Adaptive Immunity | 1 | 2012 | 714 | 0.070 |
Why?
|
Sodium Chloride | 4 | 1989 | 625 | 0.070 |
Why?
|
Hydrogen | 1 | 2007 | 164 | 0.070 |
Why?
|
Molecular Sequence Data | 6 | 2009 | 18111 | 0.070 |
Why?
|
Cell Line | 6 | 2013 | 16000 | 0.070 |
Why?
|
Sperm Capacitation | 1 | 2005 | 26 | 0.070 |
Why?
|
RNA Interference | 1 | 2015 | 2890 | 0.070 |
Why?
|
Nitric Oxide Synthase | 1 | 2009 | 915 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3873 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2861 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2004 | 5749 | 0.070 |
Why?
|
Peptides, Cyclic | 1 | 2008 | 400 | 0.070 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2006 | 300 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15078 | 0.070 |
Why?
|
Neoplasms, Experimental | 2 | 2001 | 1276 | 0.060 |
Why?
|
Membrane Potentials | 4 | 1993 | 1137 | 0.060 |
Why?
|
Male | 18 | 2014 | 350115 | 0.060 |
Why?
|
Carbon | 2 | 2007 | 687 | 0.060 |
Why?
|
Recombinant Proteins | 4 | 2011 | 6621 | 0.060 |
Why?
|
Cell Membrane | 2 | 2012 | 3749 | 0.060 |
Why?
|
Growth Substances | 1 | 1987 | 784 | 0.060 |
Why?
|
Rubidium | 4 | 1991 | 133 | 0.060 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 132 | 0.060 |
Why?
|
Proteins | 2 | 2009 | 6100 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2014 | 3759 | 0.060 |
Why?
|
Young Adult | 3 | 2021 | 56429 | 0.060 |
Why?
|
Signal Transduction | 3 | 2010 | 23404 | 0.060 |
Why?
|
Protein Binding | 4 | 2014 | 9384 | 0.060 |
Why?
|
Extracellular Space | 1 | 1985 | 595 | 0.060 |
Why?
|
Stereoisomerism | 2 | 2014 | 624 | 0.060 |
Why?
|
Ireland | 1 | 2022 | 161 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2004 | 1095 | 0.050 |
Why?
|
Mast Cells | 3 | 1979 | 1544 | 0.050 |
Why?
|
Thirst | 2 | 1979 | 38 | 0.050 |
Why?
|
Cyclin G | 1 | 2001 | 7 | 0.050 |
Why?
|
Cyclin G1 | 1 | 2001 | 17 | 0.050 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2004 | 401 | 0.050 |
Why?
|
Sperm Motility | 1 | 2003 | 253 | 0.050 |
Why?
|
Transcription Factors | 1 | 2001 | 12207 | 0.050 |
Why?
|
Proteinuria | 1 | 2004 | 658 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2010 | 1912 | 0.050 |
Why?
|
Amino Acid Sequence | 5 | 2009 | 13814 | 0.050 |
Why?
|
Receptors, Cholinergic | 2 | 2012 | 238 | 0.050 |
Why?
|
Tyrosine | 1 | 2005 | 1462 | 0.050 |
Why?
|
Ligands | 2 | 2014 | 3282 | 0.050 |
Why?
|
Liposomes | 2 | 1996 | 759 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2009 | 2232 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1988 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2006 | 1117 | 0.050 |
Why?
|
Phenotype | 3 | 2009 | 16367 | 0.050 |
Why?
|
Dehydration | 2 | 1979 | 233 | 0.050 |
Why?
|
Ribose | 1 | 2000 | 68 | 0.050 |
Why?
|
Adult | 5 | 2021 | 214052 | 0.050 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 1186 | 0.050 |
Why?
|
Ploidies | 1 | 2000 | 281 | 0.040 |
Why?
|
Heparin | 1 | 1987 | 1637 | 0.040 |
Why?
|
Cyclin E | 1 | 2000 | 172 | 0.040 |
Why?
|
Triazoles | 1 | 2005 | 908 | 0.040 |
Why?
|
Vasculitis | 1 | 2004 | 519 | 0.040 |
Why?
|
Prostaglandins E | 1 | 1979 | 172 | 0.040 |
Why?
|
Organ Specificity | 2 | 2001 | 2008 | 0.040 |
Why?
|
Hypertension, Pulmonary | 1 | 2010 | 1534 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2007 | 19233 | 0.040 |
Why?
|
Water Deprivation | 1 | 1978 | 21 | 0.040 |
Why?
|
Insulin | 1 | 2014 | 6582 | 0.040 |
Why?
|
Cyclins | 1 | 2001 | 603 | 0.040 |
Why?
|
Histamine | 2 | 1978 | 507 | 0.040 |
Why?
|
Cyclization | 2 | 2009 | 65 | 0.040 |
Why?
|
Creatinine | 1 | 2004 | 1919 | 0.040 |
Why?
|
G1 Phase | 1 | 2000 | 415 | 0.040 |
Why?
|
Cohort Studies | 1 | 2021 | 40559 | 0.040 |
Why?
|
Cattle | 2 | 1995 | 3922 | 0.040 |
Why?
|
Introns | 1 | 2001 | 992 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 3001 | 0.040 |
Why?
|
Electrophysiology | 2 | 1993 | 1308 | 0.040 |
Why?
|
K562 Cells | 1 | 2000 | 635 | 0.040 |
Why?
|
Ubiquitins | 1 | 2000 | 384 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2022 | 853 | 0.040 |
Why?
|
Base Sequence | 3 | 2006 | 12797 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 1989 | 3799 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2004 | 1146 | 0.040 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2021 | 434 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5692 | 0.040 |
Why?
|
Cloning, Molecular | 2 | 2000 | 4320 | 0.040 |
Why?
|
Time Factors | 6 | 2009 | 40075 | 0.040 |
Why?
|
Pregnant Women | 1 | 2022 | 568 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2004 | 984 | 0.040 |
Why?
|
Permeability | 2 | 1989 | 738 | 0.040 |
Why?
|
Drinking Behavior | 1 | 1977 | 103 | 0.040 |
Why?
|
Saline Solution, Hypertonic | 1 | 1977 | 110 | 0.040 |
Why?
|
Sheep | 2 | 1990 | 1437 | 0.040 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1996 | 225 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2004 | 1917 | 0.030 |
Why?
|
Molecular Weight | 2 | 1989 | 2255 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2001 | 1758 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2000 | 2256 | 0.030 |
Why?
|
Umbilical Cord | 1 | 1996 | 180 | 0.030 |
Why?
|
Adolescent | 2 | 2014 | 85779 | 0.030 |
Why?
|
Carrier Proteins | 1 | 1989 | 5023 | 0.030 |
Why?
|
Intracellular Fluid | 1 | 1995 | 203 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2001 | 2649 | 0.030 |
Why?
|
Capillary Permeability | 1 | 1978 | 798 | 0.030 |
Why?
|
ras Proteins | 1 | 2000 | 1060 | 0.030 |
Why?
|
Dextrans | 1 | 1996 | 595 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2009 | 1572 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1995 | 402 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 29786 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2008 | 506 | 0.030 |
Why?
|
RNA Caps | 1 | 2014 | 74 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 12952 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2007 | 3854 | 0.030 |
Why?
|
Glomerular Mesangium | 1 | 1994 | 108 | 0.030 |
Why?
|
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1991 | 34 | 0.030 |
Why?
|
Antigens, CD | 1 | 2004 | 4026 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 561 | 0.030 |
Why?
|
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1991 | 60 | 0.030 |
Why?
|
Solutions | 1 | 2014 | 426 | 0.030 |
Why?
|
Complement C5b | 1 | 1993 | 9 | 0.030 |
Why?
|
Charybdotoxin | 1 | 1993 | 24 | 0.030 |
Why?
|
Scorpion Venoms | 1 | 1993 | 31 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2014 | 436 | 0.030 |
Why?
|
Thymidine | 1 | 1993 | 310 | 0.030 |
Why?
|
Zymosan | 1 | 1993 | 124 | 0.030 |
Why?
|
Mitogens | 1 | 1993 | 232 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2014 | 408 | 0.030 |
Why?
|
Middle Aged | 3 | 2014 | 213390 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 459 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2001 | 4740 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1996 | 1263 | 0.030 |
Why?
|
Rabbits | 2 | 2009 | 4894 | 0.030 |
Why?
|
Electric Conductivity | 2 | 1991 | 411 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1994 | 537 | 0.030 |
Why?
|
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1991 | 20 | 0.030 |
Why?
|
Valinomycin | 1 | 1991 | 19 | 0.030 |
Why?
|
Administration, Oral | 1 | 2000 | 3914 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 1993 | 391 | 0.030 |
Why?
|
Oligomycins | 1 | 1991 | 19 | 0.030 |
Why?
|
Sharks | 1 | 1991 | 22 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 2219 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 1993 | 683 | 0.030 |
Why?
|
Cnidarian Venoms | 1 | 1991 | 19 | 0.030 |
Why?
|
Ionophores | 1 | 1991 | 108 | 0.030 |
Why?
|
Binding Sites | 2 | 2014 | 6111 | 0.030 |
Why?
|
HIV-1 | 1 | 2009 | 6939 | 0.030 |
Why?
|
Proteolipids | 1 | 1991 | 117 | 0.030 |
Why?
|
Cell Cycle | 1 | 2000 | 2967 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 475 | 0.020 |
Why?
|
Creatine Kinase | 1 | 1993 | 694 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 1247 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1723 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 2007 | 4561 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8432 | 0.020 |
Why?
|
Hemoglobins | 1 | 1996 | 1532 | 0.020 |
Why?
|
Chlorides | 2 | 1991 | 667 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2795 | 0.020 |
Why?
|
Cytotoxins | 1 | 2011 | 153 | 0.020 |
Why?
|
Methazolamide | 1 | 1989 | 9 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 3848 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1991 | 2556 | 0.020 |
Why?
|
Cytosol | 1 | 1993 | 901 | 0.020 |
Why?
|
Acrylamides | 1 | 1991 | 255 | 0.020 |
Why?
|
Mice, SCID | 1 | 1995 | 2716 | 0.020 |
Why?
|
Thermolysin | 1 | 1989 | 14 | 0.020 |
Why?
|
Hypotonic Solutions | 1 | 1989 | 49 | 0.020 |
Why?
|
Protein Conformation | 2 | 2009 | 4010 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2011 | 5974 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2014 | 2012 | 0.020 |
Why?
|
Apoptosis | 1 | 2005 | 9724 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2004 | 4251 | 0.020 |
Why?
|
Electrochemistry | 1 | 1989 | 145 | 0.020 |
Why?
|
Cations | 1 | 1989 | 232 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 1996 | 2700 | 0.020 |
Why?
|
Colloids | 1 | 1989 | 136 | 0.020 |
Why?
|
Potassium Chloride | 1 | 1989 | 237 | 0.020 |
Why?
|
Osmotic Pressure | 1 | 1989 | 151 | 0.020 |
Why?
|
Pyrans | 1 | 2009 | 54 | 0.020 |
Why?
|
Foam Cells | 1 | 2009 | 71 | 0.020 |
Why?
|
Streptococcus intermedius | 1 | 2007 | 4 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2010 | 317 | 0.020 |
Why?
|
Species Specificity | 2 | 2007 | 2478 | 0.020 |
Why?
|
Ultrafiltration | 1 | 1988 | 57 | 0.020 |
Why?
|
Interferon-gamma | 1 | 1996 | 3207 | 0.020 |
Why?
|
Circular Dichroism | 1 | 2008 | 354 | 0.020 |
Why?
|
Cations, Monovalent | 1 | 1987 | 25 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 1993 | 1579 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 472 | 0.020 |
Why?
|
Fluorenes | 1 | 2009 | 160 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1989 | 1157 | 0.020 |
Why?
|
Aged | 2 | 2014 | 163288 | 0.020 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2007 | 9 | 0.020 |
Why?
|
Cell Separation | 1 | 1993 | 1751 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1994 | 1504 | 0.020 |
Why?
|
Choroid Plexus | 1 | 1989 | 231 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 1995 | 1376 | 0.020 |
Why?
|
Biological Transport, Active | 1 | 1987 | 349 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2010 | 798 | 0.020 |
Why?
|
Cell Extracts | 1 | 2007 | 138 | 0.020 |
Why?
|
Angiotensin II | 1 | 2010 | 881 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 638 | 0.020 |
Why?
|
Neurons | 2 | 1997 | 9340 | 0.020 |
Why?
|
Lactates | 1 | 1987 | 432 | 0.020 |
Why?
|
Entropy | 1 | 2007 | 209 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2007 | 467 | 0.020 |
Why?
|
Fourier Analysis | 1 | 2007 | 447 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 2327 | 0.020 |
Why?
|
PC12 Cells | 2 | 1997 | 331 | 0.020 |
Why?
|
Type C Phospholipases | 2 | 1997 | 292 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 898 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2007 | 743 | 0.020 |
Why?
|
Perfusion | 1 | 1989 | 1360 | 0.020 |
Why?
|
Dogs | 1 | 1990 | 3912 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2001 | 9445 | 0.020 |
Why?
|
Granulocytes | 1 | 2007 | 548 | 0.020 |
Why?
|
Phosphatidylinositols | 2 | 1997 | 291 | 0.020 |
Why?
|
Endothelium | 1 | 2007 | 778 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 2 | 1997 | 424 | 0.020 |
Why?
|
Adenosine Triphosphate | 2 | 1991 | 2027 | 0.020 |
Why?
|
Obesity | 1 | 1987 | 12746 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 1988 | 634 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12721 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2000 | 4034 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2007 | 479 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2011 | 931 | 0.010 |
Why?
|
von Willebrand Factor | 1 | 2007 | 669 | 0.010 |
Why?
|
Blood Proteins | 1 | 1989 | 1124 | 0.010 |
Why?
|
Models, Animal | 1 | 2010 | 2173 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8300 | 0.010 |
Why?
|
Polysaccharides | 1 | 2009 | 1059 | 0.010 |
Why?
|
Lactic Acid | 1 | 1987 | 1132 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6386 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 1375 | 0.010 |
Why?
|
NF-kappa B | 1 | 2010 | 2499 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 1987 | 878 | 0.010 |
Why?
|
Oncogenes | 1 | 2007 | 1265 | 0.010 |
Why?
|
Dietary Fats | 1 | 2009 | 2016 | 0.010 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2000 | 94 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2010 | 2158 | 0.010 |
Why?
|
Restriction Mapping | 1 | 2000 | 878 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2000 | 803 | 0.010 |
Why?
|
DNA | 1 | 1994 | 7294 | 0.010 |
Why?
|
Prostaglandins F | 1 | 1979 | 81 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 2000 | 281 | 0.010 |
Why?
|
p-Methoxy-N-methylphenethylamine | 1 | 1979 | 41 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1596 | 0.010 |
Why?
|
Probenecid | 1 | 1979 | 76 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29060 | 0.010 |
Why?
|
Ruthenium Red | 1 | 1978 | 19 | 0.010 |
Why?
|
Histamine Release | 1 | 1978 | 142 | 0.010 |
Why?
|
Isoproterenol | 1 | 1978 | 399 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39052 | 0.010 |
Why?
|
Metiamide | 1 | 1977 | 6 | 0.010 |
Why?
|
Methysergide | 1 | 1977 | 28 | 0.010 |
Why?
|
Receptors, Histamine H2 | 1 | 1977 | 18 | 0.010 |
Why?
|
Receptors, Histamine H1 | 1 | 1977 | 18 | 0.010 |
Why?
|
Drinking | 1 | 1978 | 197 | 0.010 |
Why?
|
Blood Physiological Phenomena | 1 | 1997 | 55 | 0.010 |
Why?
|
Complement C3b | 1 | 1997 | 106 | 0.010 |
Why?
|
Diphenhydramine | 1 | 1977 | 63 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 1977 | 192 | 0.010 |
Why?
|
Cromolyn Sodium | 1 | 1977 | 87 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7323 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1997 | 6171 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2749 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1977 | 346 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2839 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5172 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12788 | 0.010 |
Why?
|
Neoplasms | 1 | 2004 | 21696 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8551 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 77460 | 0.010 |
Why?
|
Cell Count | 1 | 1978 | 1856 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2007 | 5096 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72296 | 0.010 |
Why?
|
Inflammation | 1 | 1993 | 10637 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4751 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1997 | 2505 | 0.010 |
Why?
|
Cesium | 1 | 1991 | 38 | 0.010 |
Why?
|
Vanadates | 1 | 1991 | 82 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13286 | 0.010 |
Why?
|
Drug Combinations | 1 | 1997 | 1958 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1989 | 7882 | 0.010 |
Why?
|
Cell Death | 1 | 1997 | 1707 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15535 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1995 | 13104 | 0.010 |
Why?
|
Hydrolysis | 1 | 1991 | 682 | 0.010 |
Why?
|
Sodium Channels | 1 | 1991 | 349 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 6486 | 0.010 |
Why?
|
Lithium | 1 | 1991 | 601 | 0.010 |
Why?
|
Magnesium | 1 | 1991 | 813 | 0.000 |
Why?
|
Cell Survival | 1 | 1995 | 5882 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1997 | 7721 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11366 | 0.000 |
Why?
|